Positive topline phase III results show Roche’s Vabysmo improved vision for people living with retinal vein occlusion (RVO) Read more
Outlook Therapeutics Announces Acceptance of Biologics License Application by FDA for ONS-5010 as a Treatment for Wet AMD Read more
AbbVie Announces Submissions of Regulatory Applications for Epcoritamab (DuoBody-CD3xCD20) for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Large B-Cell Lymphoma (LBCL) Read more
PTC Therapeutics Announces Strategic Financing Collaboration with Blackstone with up to $1 Billion in Funding Read more
European Medicines Agency validates ViiV Healthcare’s marketing authorisation application for cabotegravir long-acting injectable for HIV Prevention Read more
2seventy bio and JW Therapeutics Announce Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies Read more
Co-Chairs from Aerie Pharmaceuticals & Santen Inc USA Invite Industry Experts to join Ophthalmic Drugs Read more